NOLAN Daniel Joseph;ANGIOCRINE BIOSCIENCE INC.;DAVIS Claude Geoffrey;FINNEGAN Paul William;GINSBERG Michael Daniel
发明人:
FINNEGAN Paul William,DAVIS Claude Geoffrey,GINSBERG Michael Daniel,NOLAN Daniel Joseph
申请号：
IL26231018
公开号：
IL262310D0
申请日:
2018.10.11
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
The present invention provides improved methods for gene delivery to, or genetic modification of target cells, wherein the gene delivery or other genetic modification of the target cells is performed in the presence of endothelial cells, or after co-culture of the target cells with endothelial cells, or wherein co-culture of the target cells with endothelial cells is employed immediately alter gene delivery in order to “rescue” cells that may have been damaged during the gene delivery process. In some embodiments gene delivery is performed by transfection. In some embodiments gene delivery is performed by transduction, in some embodiments the endothelial cells are organ-specific endothelial cells. In some embodiments the endothelial cells are E40RF1-expressing endothelial cells (E40RF1+ ECs). In some embodiments the target cells are stem cells, such as hematopoietic stem cells.
